Applying symptom tracking to COVID-19 outpatient care using famotidine

(Cold Spring Harbor Laboratory) Researchers are developing methods to test COVID-19 treatments on non-hospitalized patients. The Northwell-CSHL team of clinicians/researchers used famotidine as a proof-of-concept that outpatient symptom tracking may accelerate prioritization of effective drug regimens to be pursued more rigorously in clinical trials.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news